These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Risk assessment in genetic techniques]. Hobom G Verh Dtsch Ges Inn Med; 1990; 96():465-9. PubMed ID: 2092466 [No Abstract] [Full Text] [Related]
3. The problems of virus containment. Wright AE; Harper GJ; Simpson DI Lab Res Methods Biol Med; 1982; 5():305-39. PubMed ID: 7043134 [No Abstract] [Full Text] [Related]
4. [Vaccine prophylaxis: contribution for the control of biologic risk in exposed workers]. Vonesch N; Tomao P; Signorini S; Palmi S; Papaleo B Med Lav; 2000; 91(3):226-50. PubMed ID: 10965671 [TBL] [Abstract][Full Text] [Related]
5. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Definitions Subcommittee. Minutes of meeting, December 5, 1988. Recomb DNA Tech Bull; 1989 Mar; 12(1):3-28. PubMed ID: 2657877 [No Abstract] [Full Text] [Related]
7. Laboratory containment practices for arthropod vectors of human and animal pathogens. Tabachnick WJ Lab Anim (NY); 2006 Mar; 35(3):28-33. PubMed ID: 16505823 [TBL] [Abstract][Full Text] [Related]
8. NRC releases evaluation of effects of Baltimore tunnel fire on rail transportation of spent nuclear fuel. Health Phys; 2003 Jun; 84(6):792-3. PubMed ID: 12822593 [No Abstract] [Full Text] [Related]
9. [Facilities, equipment, and biohazards]. Yamanouchi T Gan To Kagaku Ryoho; 1982 Jan; 9(1):146-58. PubMed ID: 7184360 [TBL] [Abstract][Full Text] [Related]
10. [Hygienic aspects of studying biologically active substances]. Sidorenko GI; Nemyria VI Gig Sanit; 1984 Mar; (3):4-6. PubMed ID: 6714724 [No Abstract] [Full Text] [Related]
11. Need for specific data on incineration of antineoplastic agents. Habeger HE Am J Hosp Pharm; 1983 Sep; 40(9):1468. PubMed ID: 6624746 [No Abstract] [Full Text] [Related]
12. [Biohazard and its elimination in the pathological examinations]. Shimada O Rinsho Byori; 1988 Jan; 36(1):35-9. PubMed ID: 3367520 [No Abstract] [Full Text] [Related]
14. NATO advanced research workshop report. Recommendations for a scientific approach to safety assurance for environmental introductions of genetically-engineered organisms. Rome, Italy, June 6-10, 1987. Recomb DNA Tech Bull; 1987 Dec; 10(4):115-22. PubMed ID: 3481095 [No Abstract] [Full Text] [Related]
15. [Health and the environment in the face of advances in biotechnology]. Lafontaine A Bull Mem Acad R Med Belg; 1984; 139(8-9):437-48. PubMed ID: 6535616 [No Abstract] [Full Text] [Related]
16. Establishing guidance for the handling and containment of new chemical entities and chemical intermediates in the pharmaceutical industry. Olson MJ; Binks SP; Newton DL; Clark GC Occup Med; 1997; 12(1):49-65. PubMed ID: 9153052 [TBL] [Abstract][Full Text] [Related]
17. Controlling ambient biohazards; what you can't see can hurt. Healthc Hazard Mater Manage; 1994 Mar; 7(6):6-8. PubMed ID: 10133015 [TBL] [Abstract][Full Text] [Related]
18. Biosafety practices associated with potential agents of biocrime and biowarfare. Burnett LC Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570 [TBL] [Abstract][Full Text] [Related]
19. A look at the P4 virus containment laboratory. van der Groen G; Trexler PC Prog Med Virol; 1982; 28():192-207. PubMed ID: 7045978 [No Abstract] [Full Text] [Related]
20. [An enzymological contribution to the solution of the problem of manure]. van Os JZ Tijdschr Diergeneeskd; 1991 Jun; 116(11):581-2. PubMed ID: 1647555 [No Abstract] [Full Text] [Related] [Next] [New Search]